Liminal BioSciences Inc. ("Liminal BioSciences" or the "Company") announced that it has discontinued development of fezagepras.
The decision to discontinue the development of fezagepras is...
ZyVersa Therapeutics, Inc., a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop product candidates that address unmet medical needs in the...
Vim, a leading technology company building a point of care connection platform for U.S. healthcare, has signed its 500th provider organization to use Vim...
Hip Innovation Technology, LLC (HIT), a medical device company developing innovative orthopedic device solutions to advance the quality of life and quality of care...
